: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

COVID-19: Daily Top 10 Papers

Autoimmune Disorders

Free Subscription

Articles published in J Neuroimmunol
Retrieve available abstracts of 453 articles:
HTML format

Single Articles

July 2021

MIMPEN M, Damoiseaux J, van Doorn W, Rolf L, et al
Proportions of circulating transitional B cells associate with MRI activity in interferon beta-treated multiple sclerosis patients.
J Neuroimmunol. 2021;358:577664.
PubMed Abstract available

CORTES-VICENTE E, Alvarez-Velasco R, Illa I, Gallardo E, et al
Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis".
J Neuroimmunol. 2021;358:577659.
PubMed

IVANOVA M, Voronkova A, Sukhorukov V, Zakharova M, et al
Different neuroinflammatory gene expression profiles in highly active and benign multiple sclerosis.
J Neuroimmunol. 2021;358:577650.
PubMed Abstract available

KHANMOHAMMADI S, Malekpour M, Jabbari P, Rezaei N, et al
Genetic basis of Guillain-Barre syndrome.
J Neuroimmunol. 2021;358:577651.
PubMed Abstract available

June 2021

MOSTAFA GA, Meguid NA, Shehab AAS, Elsaeid A, et al
Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity.
J Neuroimmunol. 2021;358:577638.
PubMed Abstract available

MIRZAEI R, Zamani F, Hajibaba M, Rasouli-Saravani A, et al
The pathogenic, therapeutic and diagnostic role of exosomal microrna in the autoimmune diseases.
J Neuroimmunol. 2021;358:577640.
PubMed Abstract available

JAKHMOLA S, Upadhyay A, Jain K, Mishra A, et al
Herpesviruses and the hidden links to Multiple Sclerosis neuropathology.
J Neuroimmunol. 2021;358:577636.
PubMed Abstract available

UZAWA A, Akamine H, Kojima Y, Ozawa Y, et al
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.
J Neuroimmunol. 2021;358:577634.
PubMed Abstract available

FINSTERER J
Steroid-responsive, transverse myelitis is a known complication of COVID-19.
J Neuroimmunol. 2021;355:577566.
PubMed

REYES S, Cunningham AL, Kalincik T, Havrdova EK, et al
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.
J Neuroimmunol. 2021;357:577627.
PubMed Abstract available

FINSTERER J, Ghosh R
Dimensions of SARS-CoV-2 associated Guillain-Barre syndrome.
J Neuroimmunol. 2021;357:577626.
PubMed

NIINO M, Fukazawa T, Miyazaki Y, Ura S, et al
Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.
J Neuroimmunol. 2021;357:577624.
PubMed Abstract available

May 2021

GRISANTI SG, Franciotta D, Garnero M, Zuppa A, et al
A case series of parainfectious Guillain-Barre syndrome linked to influenza A (H1N1) virus infection.
J Neuroimmunol. 2021;357:577605.
PubMed Abstract available

MANOUCHEHRI N, Guisso DR, Hussain RZ, Minassian BA, et al
The antioxidant MnTBAP does not effectively downregulate CD4 expression in T cells in vivo.
J Neuroimmunol. 2021;354:577544.
PubMed Abstract available

WANG T, Wang B, Zeng Z, Li H, et al
Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study.
J Neuroimmunol. 2021;354:577527.
PubMed Abstract available

FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies.
J Neuroimmunol. 2021;357:577609.
PubMed

SVIRIDOVA A, Rogovskii V, Kudrin V, Pashenkov M, et al
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis.
J Neuroimmunol. 2021;356:577608.
PubMed Abstract available

ROTOLO RA, Demuro J, Drummond G, Little C, et al
Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2021;356:577603.
PubMed Abstract available

SOLTANMORADI S, Tavakolpour V, Moghadasi AN, Kouhkan F, et al
Expression analysis of NF-kappaB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients.
J Neuroimmunol. 2021;356:577602.
PubMed Abstract available

KELLY H, Sokola B, Abboud H
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients.
J Neuroimmunol. 2021;356:577599.
PubMed Abstract available

ZULIANI L, Marangoni S, De Gaspari P, Rosellini I, et al
Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics.
J Neuroimmunol. 2021 May 1:577598. doi: 10.1016/j.jneuroim.2021.577598.
PubMed Abstract available

April 2021

YOKOTE H
Author's response in reply to "Question about data: Importance of serum amyloid A level in patients with multiple sclerosis".
J Neuroimmunol. 2021;356:577589.
PubMed

DOPPLER K, Hemprich A, Haarmann A, Brecht I, et al
Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis.
J Neuroimmunol. 2021;356:577588.
PubMed Abstract available

GARCIA-MANTEIGA JM, Clarelli F, Bonfiglio S, Mascia E, et al
Identification of differential DNA methylation associated with multiple sclerosis: A family-based study.
J Neuroimmunol. 2021;356:577600.
PubMed Abstract available

MASI G, Spagni G, Campetella L, Monte G, et al
Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis.
J Neuroimmunol. 2021;356:577601.
PubMed Abstract available

PAPRI N, Hayat S, Mohammed A, Afsar MNA, et al
Guillain-Barre syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.
J Neuroimmunol. 2021;356:577590.
PubMed Abstract available

HOU H, Sun Y, Miao J, Gao M, et al
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2021;356:577583.
PubMed Abstract available

SHEIKH AB, Chourasia PK, Javed N, Chourasia MK, et al
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review.
J Neuroimmunol. 2021;355:577577.
PubMed Abstract available

MORENO-ESCOBAR MC, Kataria S, Khan E, Subedi R, et al
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature.
J Neuroimmunol. 2021;353:577523.
PubMed Abstract available

JUMAH M, Rahman F, Figgie M, Prasad A, et al
COVID-19, HHV6 and MOG antibody: A perfect storm.
J Neuroimmunol. 2021;353:577521.
PubMed Abstract available

WANG J, Qiu Z, Li D, Dong H, et al
Anti-contactin-associated protein-like 2 antibody-associated cerebellar ataxia: A case report and literature review.
J Neuroimmunol. 2021;353:577515.
PubMed Abstract available

ZHANG H, Yang Y, Luo X
Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report.
J Neuroimmunol. 2021;353:577519.
PubMed Abstract available

LI C, Wang J, Sun X, Li R, et al
The current situation of diagnosis and treatment of neuromyelitis optica spectrum disorder: Experience with 461 cases from a single centre in South China.
J Neuroimmunol. 2021;353:577506.
PubMed Abstract available

DIEM L, Hoepner R, Bagnoud M, Salmen A, et al
Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature.
J Neuroimmunol. 2021;353:577505.
PubMed Abstract available

FANG F, Wang Y, Xu W
Anti-N-methyl-d-aspartate receptor encephalitis associated with intracranial cryptococcal infection: A case report and 2-year follow-up.
J Neuroimmunol. 2021;353:577502.
PubMed Abstract available

DU Q, Shi Z, Chen H, Zhang Y, et al
Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2021;353:577494.
PubMed Abstract available

PRADO MB JR, Narito KM, Adiao KJB
Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.
J Neuroimmunol. 2021;355:577572.
PubMed Abstract available

FAN Z, Zheng D, Wen X, Shen F, et al
CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients.
J Neuroimmunol. 2021;355:577571.
PubMed Abstract available

DINIZ SN, da Silva CF, de Almeida IT, da Silva Costa FE, et al
INFbeta treatment affects global DNA methylation in monocytes of patients with multiple sclerosis.
J Neuroimmunol. 2021;355:577563.
PubMed Abstract available

March 2021

GUEDES BF, Ribeiro AF, Pinto LF, Vidal JE, et al
Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases.
J Neuroimmunol. 2021;355:577548.
PubMed Abstract available

LAZAREVIC M, Djedovic N, Stanisavljevic S, Dimitrijevic M, et al
Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies.
J Neuroimmunol. 2021;354:577547.
PubMed Abstract available

DINOTO A, Bosco A, Sartori A, Bratina A, et al
Hiccups, severe vomiting and longitudinally extensive transverse myelitis in a patient with prostatic adenocarcinoma and Aquaporin-4 antibodies.
J Neuroimmunol. 2021;352:577488.
PubMed Abstract available

LI X, Hou C, Wu WL, Liang H, et al
Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.
J Neuroimmunol. 2021;352:577479.
PubMed Abstract available

DAY GS, Gordon BA, Bucelli RC, Perrin RJ, et al
Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient.
J Neuroimmunol. 2021;352:577474.
PubMed Abstract available

COSSU D, Yokoyama K, Sakanishi T, Kuwahara-Arai K, et al
A mucosal immune response induced by oral administration of heat-killed Mycobacterium avium subsp. paratuberculosis exacerbates EAE.
J Neuroimmunol. 2021;352:577477.
PubMed Abstract available

CHAUDHARY P, Marracci GH, Calkins E, Pocius E, et al
Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE.
J Neuroimmunol. 2021;352:577468.
PubMed Abstract available

GIARRAPUTO J, Giamberardino S, Arvai S, Maichle S, et al
Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis.
J Neuroimmunol. 2021;354:577541.
PubMed Abstract available

February 2021

XIANG W, Xie C, Guan Y
The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis.
J Neuroimmunol. 2021;354:577520.
PubMed Abstract available

LI H, Huang Z, Jia D, Xue H, et al
Low-dose rituximab treatment for new-onset generalized myasthenia gravis.
J Neuroimmunol. 2021;354:577528.
PubMed Abstract available

LUCCHINI M, Giuffre GM, Nociti V, Bianco A, et al
Defining the disease course of TNFalpha blockers-associated Multiple Sclerosis.
J Neuroimmunol. 2021;353:577525.
PubMed Abstract available

AKAISHI T, Misu T, Takahashi T, Takai Y, et al
Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders.
J Neuroimmunol. 2021;351:577467.
PubMed Abstract available

CHOUDHARY A, Bhargava A, Khichar S, Pradhan S, et al
Etiological spectrum, clinico-radiological profile and treatment outcomes of longitudinally extensive transverse myelitis - A prospective study from Northwest India.
J Neuroimmunol. 2021;351:577456.
PubMed Abstract available

THIRUNAVUKKARASU B, Gupta K, Nada R, Rathi M, et al
Neuropathological spectrum in systemic lupus erythematosus: A single institute autopsy experience.
J Neuroimmunol. 2021;353:577518.
PubMed Abstract available

UCHIDA N, Mori K, Fujita-Nakata M, Nakanishi M, et al
Systemic cellular immunity and neuroinflammation during acute flare-up in multiple sclerosis and neuromyelitis optica spectrum disorder patients.
J Neuroimmunol. 2021;353:577500.
PubMed Abstract available

LI Q, Liu Y, Zeng Y
Questions about data: Importance of serum amyloid A level in patients with multiple sclerosis.
J Neuroimmunol. 2021;353:577516.
PubMed

January 2021

YUE YX, Gao X, Tang TP, Xie Y, et al
Complement C3 polymorphism is associated with the susceptibility of myasthenia gravis in Chinese adult patients.
J Neuroimmunol. 2021;353:577487.
PubMed Abstract available

BEER R, Lehn A, Blum S
A case of Anti-LGi-1 antibody positive autoimmune epilepsy following deep brain stimulator implantation for essential tremor.
J Neuroimmunol. 2021;353:577503.
PubMed Abstract available

NING P, Yang B, Yang X, Huang H, et al
Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barre syndrome.
J Neuroimmunol. 2021;353:577504.
PubMed Abstract available

KHADEMI B, Khorrami M, Ayromlou H, Rikhtegar R, et al
An interdependence between GAPVD1 gene polymorphism, expression level and response to interferon beta in patients with multiple sclerosis.
J Neuroimmunol. 2021;353:577507.
PubMed Abstract available

BROADLEY J, Wesselingh R, Seneviratne U, Kyndt C, et al
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis.
J Neuroimmunol. 2021;353:577508.
PubMed Abstract available

MIMPEN M, Rolf L, Muris AH, Gerlach O, et al
NK/T cell ratios associate with interleukin-2 receptor alpha chain expression and shedding in multiple sclerosis.
J Neuroimmunol. 2021;353:577499.
PubMed Abstract available

ONMAZ DE, Isik SMT, Abusoglu S, Ekmekci AH, et al
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis.
J Neuroimmunol. 2021;353:577497.
PubMed Abstract available

NIU Y, Li Y
The serum alpha-synuclein levels in patients with multiple sclerosis need more evidence.
J Neuroimmunol. 2021;352:577465.
PubMed

MORIGUCHI K, Miyamoto K, Fukumoto Y, Kusunoki S, et al
Change in light-dark cycle affects experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2021;353:577495.
PubMed Abstract available

CHU Y, Jing Y, Zhao X, Wang M, et al
Modulation of the HMGB1/TLR4/NF-kappaB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2021;352:577480.
PubMed Abstract available

ZILIOTTO N, Lamberti N, Manfredini F, Straudi S, et al
Baseline and overtime variations of soluble adhesion molecule plasma concentrations are associated with mobility recovery after rehabilitation in multiple sclerosis patients.
J Neuroimmunol. 2021;352:577473.
PubMed Abstract available

December 2020

KOHLE F, Sprenger A, Klein I, Fink GR, et al
Nerve conductions studies in experimental models of autoimmune neuritis: A meta-analysis and guideline.
J Neuroimmunol. 2020;352:577470.
PubMed Abstract available

STASCHEIT F, Li L, Mai K, Baum K, et al
Delayed onset hypophysitis after therapy with daclizumab for multiple sclerosis - A report of two cases.
J Neuroimmunol. 2020;351:577469.
PubMed Abstract available

YOKOTE H, Toru S, Nishida Y, Hattori T, et al
Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis.
J Neuroimmunol. 2020;351:577466.
PubMed Abstract available

AKAISHI T, Fujimori J, Takahashi T, Misu T, et al
Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody.
J Neuroimmunol. 2020;349:577431.
PubMed Abstract available

UZAWA A, Ozawa Y, Yasuda M, Kuwabara S, et al
Severe worsening of myasthenic symptoms after the eculizumab discontinuation.
J Neuroimmunol. 2020;349:577424.
PubMed Abstract available

GARCIA-FERNANDEZ FJ, Garcia-Fernandez AE, Nava E, Del Pozo JSG, et al
A bibliometric evaluation of the top 100 cited natalizumab articles.
J Neuroimmunol. 2020;349:577379.
PubMed Abstract available

HUSSEIN O, Abd Elazim A, Torbey MT
Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM).
J Neuroimmunol. 2020;349:577405.
PubMed Abstract available

ZHENG Y, Luo J, Jin H, Gao F, et al
Cerebrospinal fluid CD20 positive B-cell expansion in a case of anti-NMDAR encephalitis.
J Neuroimmunol. 2020;349:577365.
PubMed Abstract available

November 2020

MOUTRAN-BARROSO H, Kreinter-Rosembaun H, Beltran S MA, Bayona H, et al
The multiple faces of encephalitis: Antibody profile in a case series of autoimmune encephalitis in Bogota, Colombia.
J Neuroimmunol. 2020;350:577451.
PubMed Abstract available

MA X, Kermode AG, Hu X, Qiu W, et al
NMOSD acute attack: Understanding, treatment and innovative treatment prospect.
J Neuroimmunol. 2020;348:577387.
PubMed Abstract available

GHOSH R, Dubey S, Ray BK, Purkait S, et al
Isolated opsoclonus heralding neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2020;348:577394.
PubMed Abstract available

XING X, Li J, Chen S, Zheng L, et al
Anti-CASPR2 antibody associated encephalitis with anosmia and demyelinating pseudotumor: A case report.
J Neuroimmunol. 2020;348:577393.
PubMed Abstract available

KWON YN, Kim B, Ahn S, Seo J, et al
Serum level of IL-1beta in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD).
J Neuroimmunol. 2020;348:577361.
PubMed Abstract available

GUO J, Han B, Wang J, Zhang L, et al
The differential expression and potential roles of circular RNAs in children with anti-NMDA receptor encephalitis.
J Neuroimmunol. 2020;348:577381.
PubMed Abstract available

BILGE N, Simsek F, Yevgi R, Ceylan M, et al
Low serum Alpha-SYNUCLEIN and oligomer Alpha-SYNUCLEIN levels in multiple sclerosis patients.
J Neuroimmunol. 2020;350:577432.
PubMed Abstract available

MONTEIRO A, Rosado P, Rosado L, Fonseca AM, et al
Alterations in peripheral blood monocyte and dendritic cell subset homeostasis in relapsing-remitting multiple sclerosis patients.
J Neuroimmunol. 2020;350:577433.
PubMed Abstract available

GONCALVES MVM, Brandao WN, Longo C, Peron JPS, et al
Correlation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS).
J Neuroimmunol. 2020;350:577435.
PubMed Abstract available

October 2020

SUN H, Wang J, Guo L, Wang Y, et al
The combined treatment of NAD(+) and atorvastatin ameliorates the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
J Neuroimmunol. 2020;350:577429.
PubMed Abstract available

MARTINEZ-LARROSA J, Matute-Blanch C, Montalban X, Comabella M, et al
Modelling multiple sclerosis using induced pluripotent stem cells.
J Neuroimmunol. 2020;349:577425.
PubMed Abstract available

JEBALI A, Noroozi Karimabad M, Ahmadi Z, Khorramdel H, et al
Attenuation of inflammatory response in the EAE model by PEGlated nanoliposome of pistachio oils.
J Neuroimmunol. 2020;347:577352.
PubMed Abstract available

QIU Y, Zhou Q, Du Q, Chen H, et al
Seasonal variation in relapse of neuromyelitis optica spectrum disorders: A retrospective study in China.
J Neuroimmunol. 2020;347:577351.
PubMed

DUBEY S, Ghosh R, Dubey MJ, Sengupta S, et al
Bilateral thalamic changes in anti-NMDAR encephalitis presenting with hemichorea and dystonia and acute transient psychotic disorder.
J Neuroimmunol. 2020;347:577329.
PubMed Abstract available

LI HX, Zuo L, Peng XX, Zong Q, et al
Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report.
J Neuroimmunol. 2020;347:577325.
PubMed Abstract available

September 2020

MATTEO G, Massimiliano T, Giorgia C, Silvia S, et al
AQP4 autoantibodies in patients with idiopathic normal pressure hydrocephalus.
J Neuroimmunol. 2020;349:577407.
PubMed Abstract available

NEKRASOVA I, Shirshev S
Estriol in regulation of cell-mediated immune reactions in multiple sclerosis.
J Neuroimmunol. 2020;349:577421.
PubMed Abstract available

HAWKE S, Zinger A, Juillard PG, Holdaway K, et al
Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment.
J Neuroimmunol. 2020;349:577392.
PubMed Abstract available

YAN C, Zhao R, Song J, Feng X, et al
Comparison of anti-acetylcholine receptor profiles between Chinese cases of adult- and juvenile-onset myasthenia gravis using cell-based assays.
J Neuroimmunol. 2020;349:577403.
PubMed Abstract available

YAMAKAWA M, Mukaino A, Kimura A, Nagasako Y, et al
Antibodies to the alpha3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis.
J Neuroimmunol. 2020;349:577399.
PubMed Abstract available

YILMAZ V, Tuzun E, Durmus H, Oflazer P, et al
The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients.
J Neuroimmunol. 2020;349:577402.
PubMed Abstract available

HOWLETT-PRIETO Q, Langer C, Rezania K, Soliven B, et al
Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.
J Neuroimmunol. 2020;349:577397.
PubMed Abstract available

ZHONG H, Lu J, Jing S, Xi J, et al
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients.
J Neuroimmunol. 2020;348:577383.
PubMed Abstract available

PARKHOUSE RME, Sciutto E, Hernandez M, Cortez MM, et al
Extraparenchymal human neurocysticercosis induces autoantibodies against brain tubulin and MOG35-55 in cerebral spinal fluid.
J Neuroimmunol. 2020;349:577389.
PubMed Abstract available

DAS A, Khurshid S, Hayat S, Ahmed R, et al
Glucocorticoid receptor gene polymorphisms in Guillain-Barre syndrome.
J Neuroimmunol. 2020;348:577388.
PubMed Abstract available

SIGNORIELLO E, Iardino P, Casertano S, De Lucia D, et al
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate.
J Neuroimmunol. 2020;348:577385.
PubMed Abstract available

ZOUVELOU V, Psimenou E
AChR-and MuSK-positive myasthenia gravis: Double trouble.
J Neuroimmunol. 2020;348:577364.
PubMed Abstract available

August 2020

ZHAN L, Fan M, Cai N, Cai B, et al
Combination of autoimmune pancreatitis and peripheral neuropathy on an IgG4-related disease patient with 4 years following-up.
J Neuroimmunol. 2020;348:577378.
PubMed Abstract available

HEBERT J, Gros P, Lapointe S, Amtashar FS, et al
Searching for autoimmune encephalitis: Beware of normal CSF.
J Neuroimmunol. 2020;345:577285.
PubMed Abstract available

LI X, Gao Q, Yang L, Han M, et al
Matairesinol ameliorates experimental autoimmune uveitis by suppression of IRBP-specific Th17 cells.
J Neuroimmunol. 2020;345:577286.
PubMed Abstract available

JIAO L, Xiang Y, Li S, Zhang F, et al
Efficacy of low dose rituximab in treatment-resistant CIDP with antibodies against NF-155.
J Neuroimmunol. 2020;345:577280.
PubMed Abstract available

ISMAIL S, Engin K, Ozan K, Mustafa C, et al
Analysis of plasma protein biomarkers in childhood onset multiple sclerosis.
J Neuroimmunol. 2020;348:577359.
PubMed Abstract available

TRENOVA AG, Miteva LD, Stanilova SA
Association between TNFA, IL10 and IL18 promoter gene variants and cognitive functions in patients with relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2020;347:577357.
PubMed Abstract available

SOTIROPOULOS MG, Chitnis T
Opposing and potentially antagonistic effects of BMP and TGF-beta in multiple sclerosis: The "Yin and Yang" of neuro-immune Signaling.
J Neuroimmunol. 2020;347:577358.
PubMed Abstract available

IBRAHIM SH, El-Mehdawy KM, Seleem M, El-Sawalhi MM, et al
Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression.
J Neuroimmunol. 2020;347:577356.
PubMed Abstract available

SALAVISA M, Paixao P, Ladeira AF, Mendes A, et al
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse.
J Neuroimmunol. 2020;347:577355.
PubMed Abstract available

July 2020

GARG D, Agarwal A, Bhagyawant R, Sikand TS, et al
De novo nose-pinching stereotypy with somnolence: Clues to autoimmune encephalitis.
J Neuroimmunol. 2020;347:577348.
PubMed Abstract available

ACAR NP, Tuncer A, Ozkazanc D, Ozbay FG, et al
An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta1 and fingolimod therapy.
J Neuroimmunol. 2020;347:577353.
PubMed Abstract available

GHADERIAN S, Shomali N, Behravesh S, Danbaran GR, et al
The emerging role of lncRNAs in multiple sclerosis.
J Neuroimmunol. 2020;347:577347.
PubMed Abstract available

STEFANOVIC M, Zivotic I, Stojkovic L, Dincic E, et al
The association of genetic variants IL2RA rs2104286, IFI30 rs11554159 and IKZF3 rs12946510 with multiple sclerosis onset and severity in patients from Serbia.
J Neuroimmunol. 2020;347:577346.
PubMed Abstract available

CULLER G, Bachman E, VanHaerents S
Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitis.
J Neuroimmunol. 2020;347:577324.
PubMed Abstract available

CIARDI MR, Zingaropoli MA, Pasculli P, Perri V, et al
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia.
J Neuroimmunol. 2020;346:577323.
PubMed Abstract available

KENNEDY PGE, Graner MW, Walker D, Pointon T, et al
Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.
J Neuroimmunol. 2020;347:577319.
PubMed Abstract available

TIAN X, Chen C, Ma L, Wei R, et al
Efficacy and safety of rituximab in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
J Neuroimmunol. 2020;347:577317.
PubMed Abstract available

HOUEN G, Heiden J, Trier NH, Draborg AH, et al
Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis.
J Neuroimmunol. 2020;346:577314.
PubMed Abstract available

KEYVANI H, Zahednasab H, Aljanabi HAA, Asadi M, et al
The role of human herpesvirus-6 and inflammatory markers in the pathogenesis of multiple sclerosis.
J Neuroimmunol. 2020;346:577313.
PubMed Abstract available

June 2020

YETKIN MF, Mirza M
Neutrophil to-lymphocyte ratio as a possible predictor of prognosis in recently diagnosed multiple sclerosis patients.
J Neuroimmunol. 2020;346:577307.
PubMed

FARAHMAND F, Nourshahi M, Soleimani M, Rajabi H, et al
The effect of 6 weeks of high intensity interval training on myelin biomarkers and demyelination in experimental autoimmune encephalomyelitis model.
J Neuroimmunol. 2020;346:577306.
PubMed Abstract available

FARZI MA, Ayromlou H, Jahanbakhsh N, Bavil PH, et al
Guillain-Barre syndrome in a patient infected with SARS-CoV-2, a case report.
J Neuroimmunol. 2020;346:577294.
PubMed Abstract available

AL-NASERI MAS, Salman ED, Ad'hiah AH
Relapsing-remitting multiple sclerosis: A profile of interleukine-1 gene cluster polymorphisms in Iraqi patients.
J Neuroimmunol. 2020;346:577291.
PubMed Abstract available

RYBERG B, Arvidsson A, Bergkvist M, Nilsson P, et al
Limbic encephalitis in a neuroscientist: CASPR 2 antibody-associated disease after antigen exposure.
J Neuroimmunol. 2020;343:577231.
PubMed Abstract available

JUNG KO, Moon HJ
A case of NMDAR encephalitis treated in the third trimester - novel arterial spin labeling findings and a review of literature.
J Neuroimmunol. 2020;343:577235.
PubMed Abstract available

AKAISHI T, Takahashi T, Fujihara K, Misu T, et al
Risk factors of attacks in neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2020;343:577236.
PubMed Abstract available

GONZALEZ-ALVARADO MN, Rotger C, Berger L, London B, et al
Functional role of endogenous Kv1.4 in experimental demyelination.
J Neuroimmunol. 2020;343:577227.
PubMed Abstract available

NAJJAR E, Staun-Ram E, Volkowich A, Miller A, et al
Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
J Neuroimmunol. 2020;343:577230.
PubMed Abstract available

SUN H, Ma X, Sun X, Wu L, et al
Is transient hyperCKemia a new feature of neuromyelitis optica spectrum disorders? A retrospective study in 439 patients.
J Neuroimmunol. 2020;343:577228.
PubMed Abstract available

AHARONI R, Eilam R, Schottlender N, Radomir L, et al
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
J Neuroimmunol. 2020;345:577281.
PubMed Abstract available

May 2020

RACKE MK, Newsome SD
Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration.
J Neuroimmunol. 2020 May 31:577283. doi: 10.1016/j.jneuroim.2020.577283.
PubMed

CHIARINI M, Paghera S, Moratto D, Rossi N, et al
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
J Neuroimmunol. 2020;345:577282.
PubMed Abstract available

LI Y, Guptill JT, Russo MA, Howard JF Jr, et al
Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.
J Neuroimmunol. 2020;345:577279.
PubMed Abstract available

GRIFFITH SP, Malpas CB, Alpitsis R, O'Brien TJ, et al
The neuropsychological spectrum of anti-LGI1 antibody mediated autoimmune encephalitis.
J Neuroimmunol. 2020;345:577271.
PubMed Abstract available

MAURICE C, Khoja L, Morgan E, Mason WP, et al
Guillain-Barre Syndrome following a series of novel therapies adapting the gold-standard in the era of immune priming.
J Neuroimmunol. 2020;346:577267.
PubMed Abstract available

KAPADIA RK, Ney DE, Hannan M, Farley M, et al
Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
J Neuroimmunol. 2020;344:577259.
PubMed Abstract available

April 2020

KEFALOPOULOU ZM, Liossis SN, Sagona T, Veltsista D, et al
An ischemic stroke as the presenting manifestation of rapidly progressive primary angiitis of central nervous system in a 17-year-old boy.
J Neuroimmunol. 2020;341:577190.
PubMed Abstract available

LI X, Guo Q, Zheng Z, Wang X, et al
Immune-mediated epilepsy with GAD65 antibodies.
J Neuroimmunol. 2020;341:577189.
PubMed Abstract available

BERNARDO F, Rebordao L, Rego A, Machado S, et al
Stiff person spectrum disorders: An illustrative case series of their phenotypic and antibody diversity.
J Neuroimmunol. 2020;341:577192.
PubMed Abstract available

SHIBUYA K, Tsuneyama A, Misawa S, Sekiguchi Y, et al
Different distribution of demyelination in chronic inflammatory demyelinating polyneuropathy subtypes.
J Neuroimmunol. 2020;341:577170.
PubMed Abstract available

PREVEZIANOU A, Tzartos JS, Dagklis IE, Bentenidi E, et al
Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies.
J Neuroimmunol. 2020;344:577242.
PubMed Abstract available

ANEJA J, Kuppili PP, Paul K, Panda S, et al
Antiphospholipid syndrome presenting as treatment resistant bipolar disorder and thrombocytopenia in a young male.
J Neuroimmunol. 2020;343:577238.
PubMed Abstract available

BOULLERNE AI, Adami GR, Schwartz JL, Skias D, et al
Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity.
J Neuroimmunol. 2020;343:577237.
PubMed Abstract available

PARKHOUSE RME, Carpio A, Cortez MM, von Kriegsheim A, et al
Anti-brain protein autoantibodies are detectable in extraparenchymal but not parenchymal neurocysticercosis.
J Neuroimmunol. 2020;344:577234.
PubMed Abstract available

March 2020

PRABHAT N, Chakravarty K, Pattnaik SN, Takkar A, et al
Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease - a rare presentation.
J Neuroimmunol. 2020;343:577229.
PubMed Abstract available

MUKE I, Sprenger A, Bobylev I, Wiemer V, et al
Ultrastructural characterization of mitochondrial damage in experimental autoimmune neuritis.
J Neuroimmunol. 2020;343:577218.
PubMed Abstract available

BOLDRINI VO, Brandao CO, Pimentel MLV, Vidal A, et al
Massive activity of cytotoxic cells during refractory Neuromyelitis Optica spectrum disorder.
J Neuroimmunol. 2020;340:577148.
PubMed Abstract available

AKAISHI T, Takahashi T, Himori N, Fujihara K, et al
Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2020;340:577168.
PubMed Abstract available

URIBE-SAN-MARTIN R, Ciampi E, Cruz JP, Vasquez M, et al
Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate.
J Neuroimmunol. 2020;340:577144.
PubMed Abstract available

MADDISON P, Gozzard P, Sadalage G, Ambrose PA, et al
Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome.
J Neuroimmunol. 2020;340:577149.
PubMed Abstract available

PEDAPATI R, Bhatia R, Singh N, Bali P, et al
Anti-myelin oligodendrocyte glycoprotein antibody associated disease spectrum - A north Indian tertiary care centre experience and review of literature.
J Neuroimmunol. 2020;340:577143.
PubMed Abstract available

MACCHI ZA, Kleinschmidt-DeMasters BK, Orjuela KD, Pastula DM, et al
Glioblastoma as an autoimmune limbic encephalitis mimic: A case and review of the literature.
J Neuroimmunol. 2020;342:577214.
PubMed Abstract available

PETKOVIC F, Lazzarino GP, Engblom D, Blomqvist A, et al
IL-6R expressed on CNS vascular endothelial cells contributes to the development of experimental autoimmune encephalomyelitis in mice.
J Neuroimmunol. 2020;342:577211.
PubMed Abstract available

TAHMASEBIVAND M, Mousavi SR, Khorrami M, Ayromlou H, et al
miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta.
J Neuroimmunol. 2020;342:577212.
PubMed Abstract available

MCGILL MM, Sabikunnahar B, Fang Q, Teuscher C, et al
The sex-specific role of p38 MAP kinase in CNS autoimmunity is regulated by estrogen receptor alpha.
J Neuroimmunol. 2020;342:577209.
PubMed

February 2020

PEREZ CA, Shah EG, Butler IJ
Mercury-induced autoimmunity: Report of two adolescent siblings with Morvan syndrome "plus" and review of the literature.
J Neuroimmunol. 2020;342:577197.
PubMed Abstract available

LISAK RP, Nedelkoska L, Benjamins JA
Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis.
J Neuroimmunol. 2020;342:577188.
PubMed Abstract available

OGATA H, Isobe N, Zhang X, Yamasaki R, et al
Unique HLA haplotype associations in IgG4 anti-neurofascin 155 antibody-positive chronic inflammatory demyelinating polyneuropathy.
J Neuroimmunol. 2020;339:577139.
PubMed Abstract available

SHI Z, Qiu Y, Wang J, Fang Y, et al
Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
J Neuroimmunol. 2020;339:577126.
PubMed Abstract available

BRILL L, Vaknin-Dembinsky A, Zveik O, Haham N, et al
MIF -173G/C polymorphism is associated with NMO disease severity.
J Neuroimmunol. 2020;339:577120.
PubMed Abstract available

GARIMELLA V, McVoy JS, Oh U
The contribution of cyclophilin A to immune-mediated central nervous system inflammation.
J Neuroimmunol. 2020;339:577118.
PubMed Abstract available

ZHANG W, Dong M, Dong H, Wang W, et al
Reduced sarcolemmal aquaporin 4 expression can support the differential diagnosis of neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2020;339:577121.
PubMed Abstract available

GOMES NA, Silva PC, Teixeira YT, Eufrazio P, et al
HLA-G Ins/Del polymorphism and +3142C/G SNP are not related to neuromyelitis optica spectrum disorder (NMOSD) development, disability status or anti-aquaporin 4 presence in Brazilian patients.
J Neuroimmunol. 2020;339:577112.
PubMed Abstract available

NYSTAD AE, Lereim RR, Wergeland S, Oveland E, et al
Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model.
J Neuroimmunol. 2020;339:577091.
PubMed Abstract available

HABIB R, Ocklenburg S, Hoffjan S, Haghikia A, et al
Association between shorter leukocyte telomeres and multiple sclerosis.
J Neuroimmunol. 2020;341:577187.
PubMed Abstract available

TRAN GT, Hodgkinson SJ, Carter N, Verma ND, et al
Autoantigen specific IL-2 activated CD4(+)CD25(+)T regulatory cells inhibit induction of experimental autoimmune neuritis.
J Neuroimmunol. 2020;341:577186.
PubMed Abstract available

January 2020

SHAHIDI SH, Kordi MR, Rajabi H, Malm C, et al
Exercise modulates the levels of growth inhibitor genes before and after multiple sclerosis.
J Neuroimmunol. 2020;341:577172.
PubMed Abstract available

HEMING M, Lohmann L, Schulte-Mecklenbeck A, Brix T, et al
Leukocyte profiles in blood and CSF distinguish neurosarcoidosis from multiple sclerosis.
J Neuroimmunol. 2020;341:577171.
PubMed Abstract available

SAHAMI-FARD MH, Mozhdeh M, Izadpanah F, Kashani HH, et al
Interleukin 7 receptor T244I polymorphism and the multiple sclerosis susceptibility: a meta-analysis.
J Neuroimmunol. 2020;341:577166.
PubMed Abstract available

LIU S, Zhang X, Wang J, Yang H, et al
Analysis of plasma autoantibodies for inflammatory cytokines in patients with first-episode schizophrenia among a Chinese population.
J Neuroimmunol. 2020;341:577165.
PubMed Abstract available

ZHANG Y, Zhang Q, Shi Z, Chen H, et al
Sexual dysfunction in patients with neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2020;338:577093.
PubMed Abstract available

AGASING AM, Gawde S, Kumar G, Turner E, et al
B cell function impacts the efficacy of IFN-beta therapy in EAE.
J Neuroimmunol. 2020;338:577106.
PubMed Abstract available

BLACKBURN K, Wang C, Greenberg B
Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma.
J Neuroimmunol. 2020;338:577092.
PubMed Abstract available

DAS NEVES SP, Santos G, Barros C, Pereira DR, et al
Enhanced cognitive performance in experimental autoimmune encephalomyelitis mice treated with dimethyl fumarate after the appearance of disease symptoms.
J Neuroimmunol. 2020;340:577163.
PubMed Abstract available

PANDYA D, Hellerslia V, Gettings E
Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon beta-1a.
J Neuroimmunol. 2020;340:577146.
PubMed Abstract available

HAKANSSON I, Ernerudh J, Vrethem M, Dahle C, et al
Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis.
J Neuroimmunol. 2020;340:577147.
PubMed Abstract available

December 2019

NOVIKOVA NS, Diatlova AS, Derevtsova KZ, Korneva EA, et al
Corrigendum to "Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis" [J Neuroimmunol. 2019 Dec 15;337:577070. doi: 10.1016/j.jneuroim.2019.577070. Epub 2019 Oct 24].
J Neuroimmunol. 2019 Dec 27:577137. doi: 10.1016/j.jneuroim.2019.577137.
PubMed

JOOB B, Wiwanitkit V
Tumor necrosis factor alpha -863C/A polymorphism and Guillain-Barre Syndrome.
J Neuroimmunol. 2019;339:577140.
PubMed

LAZARIDIS K, Baltatzidou V, Tektonidis N, Tzartos SJ, et al
Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis.
J Neuroimmunol. 2019;339:577136.
PubMed Abstract available

SHIMASAKI C, Frye RE, Trifiletti R, Cooperstock M, et al
Evaluation of the Cunningham Panel in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes
J Neuroimmunol. 2019;339:577138.
PubMed Abstract available

UZAWA A, Ozawa Y, Yasuda M, Oda F, et al
Increased serum acetylcholine receptor alpha1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis.
J Neuroimmunol. 2019;339:577125.
PubMed Abstract available

PEREZ CA, Agyei P, Gogia B, Harrison R, et al
Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
J Neuroimmunol. 2019;339:577124.
PubMed Abstract available

CAVALLA P, Caropreso P, Limoncelli S, Bosa C, et al
Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders.
J Neuroimmunol. 2019;339:577122.
PubMed Abstract available

November 2019

MONTEIRO A, Rosado P, Rosado L, Fonseca AM, et al
Alterations in circulating T cell functional subpopulations in interferon-beta treated multiple sclerosis patients: A pilot study.
J Neuroimmunol. 2019;339:577113.
PubMed Abstract available

MARCUCCI SB, Obeidat AZ
EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis.
J Neuroimmunol. 2019;339:577116.
PubMed Abstract available

GLENN JD, Pantoja IM, Caturegli P, Whartenby KA, et al
MYMD-1, a novel alkaloid compound, ameliorates the course of experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019;339:577115.
PubMed Abstract available

AMMITZBOLL C, von Essen MR, Chow HH, McWilliam O, et al
MAIT cell subtypes in multiple sclerosis.
J Neuroimmunol. 2019;339:577117.
PubMed Abstract available

SPANIER JA, Nashold FE, Nelson CD, Praska CE, et al
Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4(+) T cell CTLA-4 expression.
J Neuroimmunol. 2019;338:577105.
PubMed Abstract available

NASI M, Bianchini E, De Biasi S, Gibellini L, et al
Increased plasma levels of mitochondrial DNA and pro-inflammatory cytokines in patients with progressive multiple sclerosis.
J Neuroimmunol. 2019;338:577107.
PubMed Abstract available

GAETANI L, Di Carlo M, Brachelente G, Valletta F, et al
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
J Neuroimmunol. 2019;339:577108.
PubMed Abstract available

ARRU G, Sechi E, Mariotto S, Zarbo IR, et al
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD.
J Neuroimmunol. 2019;338:577110.
PubMed Abstract available

October 2019

CAO Q, Zheng C, Xie Z, Liu L, et al
The change of PD1, PDL1 in experimental autoimmune encephalomyelitis treated by 1,25(OH)2D3.
J Neuroimmunol. 2019;338:577079.
PubMed Abstract available

KOLIC I, Stojkovic L, Dincic E, Jovanovic I, et al
Expression of LEP, LEPR and PGC1A genes is altered in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2019;338:577090.
PubMed Abstract available

NOVIKOVA NS, Diatlova AS, Derevtsova KZ, Korneva EA, et al
Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019;337:577070.
PubMed Abstract available

HAN J, Zhang J, Li M, Zhang Y, et al
A novel MuSK cell-based myasthenia gravis diagnostic assay.
J Neuroimmunol. 2019;337:577076.
PubMed Abstract available

BASNYAT P, Sumelahti ML, Lehtimaki T, Elovaara I, et al
Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.
J Neuroimmunol. 2019;335:577020.
PubMed Abstract available

SOUTO EB, Lima B, Campos JR, Martins-Gomes C, et al
Myasthenia gravis: State of the art and new therapeutic strategies.
J Neuroimmunol. 2019;337:577080.
PubMed Abstract available

KAMMEYER R, Piquet AL
Multiple co-existing antibodies in autoimmune encephalitis: A case and review of the literature.
J Neuroimmunol. 2019;337:577084.
PubMed Abstract available

PETERSEN ER, Ammitzboll C, Sondergaard HB, Oturai AB, et al
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis.
J Neuroimmunol. 2019;337:577085.
PubMed Abstract available

September 2019

RANJBAR R, Karampoor S, Jalilian FA
The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis.
J Neuroimmunol. 2019;337:577069.
PubMed Abstract available

BOYAO Y, Mengjiao S, Caicai B, Xiaoling L, et al
Dynamic expression of autophagy-related factors in autoimmune encephalomyelitis and exploration of curcumin therapy.
J Neuroimmunol. 2019;337:577067.
PubMed Abstract available

KURTUNCU M, Yilmaz V, Akcay HI, Turkoglu R, et al
Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
J Neuroimmunol. 2019;337:577065.
PubMed Abstract available

CARLOS CE, Gianfranco CS, Miguel CC, Crist EA, et al
Is there a significant association between tumor necrosis factor alpha -863C/A polymorphism and the development of Guillain-Barre Syndrome?
J Neuroimmunol. 2019;337:577064.
PubMed

ABDEL-DAYEM MA, Shaker ME, Gameil NM
Impact of interferon beta-1b, interferon beta-1a and fingolimod therapies on serum interleukins-22, 32alpha and 34 concentrations in patients with relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2019;337:577062.
PubMed Abstract available

AFSHAR B, Khalifehzadeh-Esfahani Z, Seyfizadeh N, Rezaei Danbaran G, et al
The role of immune regulatory molecules in multiple sclerosis.
J Neuroimmunol. 2019;337:577061.
PubMed Abstract available

MARGONI M, Carotenuto A
Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: A puzzle of autoimmunity.
J Neuroimmunol. 2019;337:577051.
PubMed Abstract available

BROOKS PT, Bell JA, Bejcek CE, Malik A, et al
An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
J Neuroimmunol. 2019;337:577048.
PubMed Abstract available

August 2019

LIANG H, Gao W, Liu X, Liu J, et al
The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.
J Neuroimmunol. 2019;337:577045.
PubMed Abstract available

ZAROBKIEWICZ MK, Kowalska W, Halczuk P, Wos J, et al
RORgammaT is overexpressed in iNKT and gammadelta T cells during relapse in relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2019;337:577046.
PubMed Abstract available

ZHANG G, Wang Q, Song Y, Cheng P, et al
Intravenous immunoglobulin promotes the proliferation of CD4(+)CD25(+) Foxp3(+) regulatory T cells and the cytokines secretion in patients with Guillain-Barre syndrome in vitro.
J Neuroimmunol. 2019;336:577042.
PubMed Abstract available

SVEINSSON O, Piehl F, Aspegren O, Hietala MA, et al
Successful combined treatment with thymectomy, rituximab and tocilizumab for severe thymoma-associated multi autoimmune syndrome.
J Neuroimmunol. 2019;336:577028.
PubMed Abstract available

DURCAN R, Heffron C, Sweeney B
Natalizumab induced cutaneous sarcoidosis-like reaction.
J Neuroimmunol. 2019;333:476955.
PubMed Abstract available

KAUSHANSKY N, Kaminitz A, Allouche-Arnon H, Ben-Nun A, et al
Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c(+)CD11b(+)Gr1(+) myeloid-derived dendritic cells.
J Neuroimmunol. 2019;333:476953.
PubMed Abstract available

July 2019

NAKAMURA Y, Igaki K, Uga K, Shibata A, et al
Pharmacological evaluation of TAK-828F, a novel orally available RORgammat inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model.
J Neuroimmunol. 2019;335:577016.
PubMed Abstract available

NOSADINI M, Toldo I, Tascini B, Bien CG, et al
LGI1 and CASPR2 autoimmunity in children: Systematic literature review and report of a young girl with Morvan syndrome.
J Neuroimmunol. 2019;335:577008.
PubMed Abstract available

DEL FABBRO L, de Gomes MG, Souza LC, Goes AR, et al
Chrysin suppress immune responses and protects from experimental autoimmune encephalomyelitis in mice.
J Neuroimmunol. 2019;335:577007.
PubMed Abstract available

NICOLETTI F, Mazzon E, Fagone P, Mangano K, et al
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.
J Neuroimmunol. 2019;332:224-232.
PubMed Abstract available

DZANGUE-TCHOUPOU G, Allenbach Y, Preusse C, Stenzel W, et al
Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome.
J Neuroimmunol. 2019;332:212-215.
PubMed Abstract available

JAZEBI N, Rodrigo S, Gogia B, Shawagfeh A, et al
Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
J Neuroimmunol. 2019;332:135-137.
PubMed Abstract available

ENRIQUEZ CAG, Espiritu AI, Pasco PMD
Efficacy and tolerability of mitoxantrone for neuromyelitis optica spectrum disorder: A systematic review.
J Neuroimmunol. 2019;332:126-134.
PubMed Abstract available

NEEDHAM EJ, Helmy A, Zanier ER, Jones JL, et al
The immunological response to traumatic brain injury.
J Neuroimmunol. 2019;332:112-125.
PubMed Abstract available

FREUND B, Ritzl EK
A review of EEG in anti-NMDA receptor encephalitis.
J Neuroimmunol. 2019;332:64-68.
PubMed Abstract available

CAVALIERE E, Nosadini M, Pelizza MF, Ventura G, et al
Anti-NMDAR encephalitis preceded by non-herpetic central nervous system infection: Systematic literature review and first case of tick-borne encephalitis triggering anti-NMDAR encephalitis.
J Neuroimmunol. 2019;332:1-7.
PubMed Abstract available

June 2019

KIMURA A, Takemura M, Yamamoto Y, Hayashi Y, et al
Cytokines and biological markers in autoimmune GFAP astrocytopathy: The potential role for pathogenesis and therapeutic implications.
J Neuroimmunol. 2019;334:576999.
PubMed Abstract available

NICKEL M, Eid F, Jukkola P, Gu C, et al
Copper chelation and autoimmunity differentially impact myelin in the hippocampal-prefrontal circuit.
J Neuroimmunol. 2019;334:576998.
PubMed Abstract available

LAMPORT AC, Chedrawe M, Nichols M, Robertson GS, et al
Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum.
J Neuroimmunol. 2019;334:576995.
PubMed Abstract available

IMITOLA J
Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repair.
J Neuroimmunol. 2019;331:1-3.
PubMed

ANTEL JP, Lin YH, Cui QL, Pernin F, et al
Immunology of oligodendrocyte precursor cells in vivo and in vitro.
J Neuroimmunol. 2019;331:28-35.
PubMed Abstract available

ZORLU N, Hoffjan S, Haghikia A, Deyneko IV, et al
Evaluation of variation in genes of the arylhydrocarbon receptor pathway for an association with multiple sclerosis.
J Neuroimmunol. 2019;334:576979.
PubMed Abstract available

May 2019

KOCH MW, Liu WQ, Camara-Lemarroy C, Zhang Y, et al
Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosis.
J Neuroimmunol. 2019;334:576974.
PubMed Abstract available

ZURAWSKA A, Mycko MP, Selmaj KW
Circular RNAs as a novel layer of regulatory mechanism in multiple sclerosis.
J Neuroimmunol. 2019;334:576971.
PubMed Abstract available

RASOOLI TEHRANI A, Gholipour S, Sharifi R, Yadegari S, et al
Plasma levels of CTRP-3, CTRP-9 and apelin in women with multiple sclerosis.
J Neuroimmunol. 2019;333:576968.
PubMed Abstract available

TOMESCU-BACIU A, Johansen JN, Holmoy T, Greiff V, et al
Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.
J Neuroimmunol. 2019;333:576966.
PubMed Abstract available

SHOU J, Peng J, Zhao Z, Huang X, et al
CCL26 and CCR3 are associated with the acute inflammatory response in the CNS in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019;333:576967.
PubMed Abstract available

XU H, Zhang M, Li XL, Li H, et al
Corrigendum to: "low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways" [Journal of Neuroimmunology 281 (2015) 61-67].
J Neuroimmunol. 2019;330:181-183.
PubMed

QU Z, Zheng N, Wei Y, Chen Y, et al
Effect of cornel iridoid glycoside on microglia activation through suppression of the JAK/STAT signalling pathway.
J Neuroimmunol. 2019;330:96-107.
PubMed Abstract available

SHOUMAN K, Prieto PG, Stino AM, Lisak RP, et al
Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder.
J Neuroimmunol. 2019;330:87-89.
PubMed Abstract available

DENG B, Yu H, Liu X, Yu X, et al
Reduced dosage rituximab in the treatment of anti-N-methyl-d-aspartate receptor encephalitis: An observation study in Chinese patients.
J Neuroimmunol. 2019;330:81-86.
PubMed Abstract available

KELLER CW, Quast I, Dalakas MC, Lunemann JD, et al
IVIG efficacy in CIDP patients is not associated with terminal complement inhibition.
J Neuroimmunol. 2019;330:23-27.
PubMed Abstract available

KAMO H, Ueno Y, Sugiyama M, Miyamoto N, et al
Pontine hemorrhage accompanied by neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2019;330:19-22.
PubMed Abstract available

MONTEIRO C, Fernandes G, Kasahara TM, Barros PO, et al
The expansion of circulating IL-6 and IL-17-secreting follicular helper T cells is associated with neurological disabilities in neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2019;330:12-18.
PubMed Abstract available

SPENCE S, Ng D, Casault C
Atypical presentation of fulminant primary central nervous system angiitis.
J Neuroimmunol. 2019;330:1-4.
PubMed Abstract available

BRIANI C, Salvalaggio A, Ruiz M, Cacciavillani M, et al
Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
J Neuroimmunol. 2019;330:178-180.
PubMed Abstract available

YOON L, Kim BR, Kim HY, Kwak MJ, et al
Clinical characterization of anti-GQ1b antibody syndrome in Korean children.
J Neuroimmunol. 2019;330:170-173.
PubMed Abstract available

JING S, Lu J, Song J, Luo S, et al
Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis.
J Neuroimmunol. 2019;332:216-223.
PubMed Abstract available

LOVETT-RACKE AE, Gormley M, Liu Y, Yang Y, et al
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patients.
J Neuroimmunol. 2019;332:187-197.
PubMed Abstract available

BORHANI-HAGHIGHI M, Mohamadi Y
The therapeutic effect of platelet-rich plasma on the experimental autoimmune encephalomyelitis mice.
J Neuroimmunol. 2019;333:476958.
PubMed Abstract available

April 2019

SETIADI AF, Abbas AR, Jeet S, Wong K, et al
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2019;332:147-154.
PubMed Abstract available

KIRA JI, Isobe N
Helicobacter pylori infection and demyelinating disease of the central nervous system.
J Neuroimmunol. 2019;329:14-19.
PubMed Abstract available

KIMURA A, Takekoshi A, Yoshikura N, Hayashi Y, et al
Clinical characteristics of autoimmune GFAP astrocytopathy.
J Neuroimmunol. 2019;332:91-98.
PubMed Abstract available

MADDISON P, Sadalage G, Ambrose PA, Jacob S, et al
False-positive acetylcholine receptor antibody results in patients without myasthenia gravis.
J Neuroimmunol. 2019;332:69-72.
PubMed Abstract available

SUN Y, Jing Y, Huang M, Ma J, et al
The PD-1/PD-Ls pathway is up-regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides.
J Neuroimmunol. 2019;332:78-90.
PubMed Abstract available

March 2019

SCHLIFFKE S, Carambia A, Akyuz N, Thiele B, et al
T-cell repertoire profiling by next-generation sequencing reveals tissue migration dynamics of TRBV13-family clonotypes in a common experimental autoimmune encephalomyelitis mouse model.
J Neuroimmunol. 2019;332:49-56.
PubMed Abstract available

VAITAITIS GM, Yussman MG, Wagner DH Jr
A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019;332:8-15.
PubMed Abstract available

ROJC B, Podnar B, Graus F
A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.
J Neuroimmunol. 2019;328:86-88.
PubMed Abstract available

GARG M, Mittal J, Gupta P
Association of typhoid fever with anti-NMDAR encephalitis in a young child.
J Neuroimmunol. 2019;328:76-77.
PubMed

GASTALDI M, Arbasino C, Dallocchio C, Diamanti L, et al
NMDAR encephalitis presenting as akinesia in a patient with Parkinson disease.
J Neuroimmunol. 2019;328:35-37.
PubMed Abstract available

VOO VTF, O'Brien T, Butzkueven H, Monif M, et al
The role of vitamin D and P2X7R in multiple sclerosis.
J Neuroimmunol. 2019;330:159-169.
PubMed Abstract available

HILLIS JM, Mateen FJ
Neuromyelitis optica after splenectomy: A secondary autoimmune phenomenon.
J Neuroimmunol. 2019;330:152-154.
PubMed Abstract available

CIERNY D, Michalik J, Dubovan P, Skerenova M, et al
The association of rs703842 variants in CYP27B1 with multiple sclerosis susceptibility is influenced by the HLA-DRB1*15:01 allele in Slovaks.
J Neuroimmunol. 2019;330:123-129.
PubMed Abstract available

ANNUNZIATA P, Masi G, Cioni C
Association of circulating anti-CD64 IgM levels with favourable long-term clinical outcomes in multiple sclerosis patients.
J Neuroimmunol. 2019;330:130-135.
PubMed Abstract available

AMMITZBOLL C, Bornsen L, Petersen ER, Oturai AB, et al
Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.
J Neuroimmunol. 2019;330:90-95.
PubMed Abstract available

February 2019

ZHANG DQ, Deng Y, Zhang LJ, Li LM, et al
Elevated resistin levels may regulate high mobility group box 1 expression in Guillain-Barre syndrome.
J Neuroimmunol. 2019;330:59-66.
PubMed Abstract available

DA SILVA BERNARDES M, Antao Paiva CL, Ribeiro Paradela E, Papais Alvarenga M, et al
Familial multiple sclerosis in a Brazilian sample: Is HLA-DR15 involved in susceptibility to the disease?
J Neuroimmunol. 2019;330:74-80.
PubMed Abstract available

ZAROBKIEWICZ MK, Kowalska W, Rolinski J, Bojarska-Junak AA, et al
gammadelta T lymphocytes in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019;330:67-73.
PubMed Abstract available

AL-TEMAIMI R, Cherian P, Abu-Farha M, Alroughani R, et al
Angiopoietin-like proteins in multiple sclerosis.
J Neuroimmunol. 2019;330:31-34.
PubMed Abstract available

GILLINDER L, Papacostas J, Dionisio S
Electroclinical insights into autoimmune epilepsy.
J Neuroimmunol. 2019;330:44-47.
PubMed Abstract available

SAVAGE SA, Irani SR, Leite MI, Zeman AZ, et al
NMDA receptor antibody encephalitis presenting as Transient Epileptic Amnesia.
J Neuroimmunol. 2019;327:41-43.
PubMed Abstract available

January 2019

COSSU D, Yokoyama K, Sakanishi T, Momotani E, et al
Adjuvant and antigenic properties of Mycobacterium avium subsp. paratuberculosis on experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2019 Jan 23. pii: S0165-5728(18)30552.
PubMed Abstract available

JAYASIMHAN A, Ellis DP, Ziegler AI, Slattery RM, et al
Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice.
J Neuroimmunol. 2019 Jan 18. pii: S0165-5728(18)30263.
PubMed Abstract available

MAUSNER-FAINBERG K, Penn M, Golan M, Benhamou M, et al
Reduced levels of Coco in sera of multiple sclerosis patients: A potential role in neuro-regeneration failure.
J Neuroimmunol. 2019 Jan 17. pii: S0165-5728(18)30476.
PubMed Abstract available

DOLATI S, Babaloo Z, Ayromlou H, Ahmadi M, et al
Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis.
J Neuroimmunol. 2019 Jan 17. pii: S0165-5728(18)30466.
PubMed Abstract available

KOHLER S, Keil T, Alexander T, Thiel A, et al
Altered naive CD4(+) T cell homeostasis in myasthenia gravis and thymoma patients.
J Neuroimmunol. 2019 Jan 11. pii: S0165-5728(18)30380.
PubMed Abstract available

December 2018

EMAMI ALEAGHA MS, Siroos B, Allameh A, Shakiba S, et al
Calcitriol, but not FGF23, increases in CSF and serum of MS patients.
J Neuroimmunol. 2018;328:89-93.
PubMed Abstract available

DEMIR S, Pitarokoili K, Linker R, Gold R, et al
Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model.
J Neuroimmunol. 2018;328:78-85.
PubMed Abstract available

ARAMIDEH KHOUY R, Karampoor S, Keyvani H, Bokharaei-Salim F, et al
The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
J Neuroimmunol. 2018;328:94-97.
PubMed Abstract available

XIE Y, Li Z, Wang Y, Xue X, et al
Effects of moderate- versus high- intensity swimming training on inflammatory and CD4(+) T cell subset profiles in experimental autoimmune encephalomyelitis mice.
J Neuroimmunol. 2018;328:60-67.
PubMed Abstract available

MEHTA D, Wani S, Wallace L, Henders AK, et al
Cumulative influence of parity-related genomic changes in multiple sclerosis.
J Neuroimmunol. 2018;328:38-49.
PubMed Abstract available

YOUSEFI F, Lavi Arab F, Saeidi K, Amiri H, et al
Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection.
J Neuroimmunol. 2018;328:20-34.
PubMed Abstract available

November 2018

LEE EJ, Lim YM, Kim SY, Lee J, et al
The clinical and prognostic value of antinuclear antibodies in NMO-IgG seropositive neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2018;328:1-4.
PubMed Abstract available

MASOUMI F, Ghorbani S, Talebi F, Branton WG, et al
Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;328:50-59.
PubMed Abstract available

MONTEIRO A, Cruto C, Rosado P, Rosado L, et al
Interferon-beta treated-multiple sclerosis patients exhibit a decreased ratio between immature/transitional B cell subset and plasmablasts.
J Neuroimmunol. 2018;326:49-54.
PubMed Abstract available

ANNIBALI V, Umeton R, Palermo A, Severa M, et al
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients.
J Neuroimmunol. 2018;324:165-171.
PubMed Abstract available

LOTAN I, Hellmann MA, Benninger F, Stiebel-Kalish H, et al
Recurrent optic neuritis - Different patterns in multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody disease.
J Neuroimmunol. 2018;324:115-118.
PubMed Abstract available

MOORE JR, Hubler SL, Nelson CD, Nashold FE, et al
1,25-Dihydroxyvitamin D3 increases the methionine cycle, CD4(+) T cell DNA methylation and Helios(+)Foxp3(+) T regulatory cells to reverse autoimmune neurodegenerative disease.
J Neuroimmunol. 2018;324:100-114.
PubMed Abstract available

ROCHA NP, Colpo GD, Bravo-Alegria J, Lincoln JA, et al
Exploring the relationship between Endothelin-1 and peripheral inflammation in multiple sclerosis.
J Neuroimmunol. 2018;326:45-48.
PubMed Abstract available

WANG SX, Yang CL, Zhang M, Zhang P, et al
Sulfatides ameliorate experimental autoimmune neuritis by suppressing Th1/Th17 cells.
J Neuroimmunol. 2018;326:55-61.
PubMed Abstract available

BOUXIN M, Schvartz B, Mestrallet S, Debrumetz A, et al
Rituximab treatment in seronegative autoimmune autonomic neuropathy and autoimmune autonomic ganglionopathy: Case-report and literature review.
J Neuroimmunol. 2018;326:28-32.
PubMed Abstract available

JENSEN PEH, Warnke C, Ingenhoven K, Piccoli L, et al
Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
J Neuroimmunol. 2018;326:19-27.
PubMed Abstract available

October 2018

RAMIREZ GA, Coletto LA, Bozzolo EP, Citterio L, et al
The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function.
J Neuroimmunol. 2018;325:43-53.
PubMed Abstract available

CAVAZZANA I, Alberici A, Bonomi E, Ottaviani R, et al
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg?
J Neuroimmunol. 2018;325:61-63.
PubMed Abstract available

SAFIZADEH B, Hoshyar R, Mehrpour M, Eftekhar M, et al
The role of expression and activity of 15-Lipoxygenase isoforms and related cytokines in patients with Multiple Sclerosis and healthy controls.
J Neuroimmunol. 2018;325:32-42.
PubMed Abstract available

ROSSETTI I, Zambusi L, Finardi A, Bodini A, et al
Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;323:94-104.
PubMed Abstract available

KVISTAD SS, Myhr KM, Holmoy T, Benth JS, et al
Serum levels of leptin and adiponectin are not associated with disease activity or treatment response in multiple sclerosis.
J Neuroimmunol. 2018;323:73-77.
PubMed Abstract available

DUBEY D, Kothapalli N, McKeon A, Flanagan EP, et al
Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction.
J Neuroimmunol. 2018;323:62-72.
PubMed Abstract available

DUBEY D, Hussain RZ, Miller-Little WA, Salter A, et al
PDCB does not promote CNS autoimmunity in the context of genetic susceptibility but worsens its outcome.
J Neuroimmunol. 2018;323:53-55.
PubMed Abstract available

SLAVIN YN, Bo M, Caggiu E, Sechi G, et al
High levels of antibodies against PtpA and PknG secreted by Mycobacterium avium ssp. paratuberculosis are present in neuromyelitis optica spectrum disorder and multiple sclerosis patients.
J Neuroimmunol. 2018;323:49-52.
PubMed Abstract available

AMORUSO A, Blonda M, D'Arrigo G, Grasso R, et al
Effect of fingolimod action on the release of monocyte-derived microvesicles in multiple sclerosis patients.
J Neuroimmunol. 2018;323:43-48.
PubMed Abstract available

HOCAOGLU M, Durmus H, Ozkan B, Yentur SP, et al
Increased costimulatory molecule expression of thymic and peripheral B cells and a sensitivity to IL-21 in myasthenia gravis.
J Neuroimmunol. 2018;323:36-42.
PubMed Abstract available

HAARMANN A, Hahnel L, Schuhmann MK, Buttmann M, et al
Age-adjusted CSF beta2-microglobulin and lactate are increased and ACE is decreased in patients with multiple sclerosis, but only lactate correlates with clinical disease duration and severity.
J Neuroimmunol. 2018;323:19-27.
PubMed Abstract available

SHAKERIAN L, Ghorbani S, Talebi F, Noorbakhsh F, et al
MicroRNA-150 targets PU.1 and regulates macrophage differentiation and function in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;323:167-174.
PubMed Abstract available

DEBNATH M, Nagappa M, Subbanna M, Sundaravadivel P, et al
Th17 pathway signatures in a large Indian cohort of Guillain Barre syndrome.
J Neuroimmunol. 2018;323:125-130.
PubMed Abstract available

BLUM S, Ji Y, Pennisi D, Li Z, et al
Genome-wide association study in Guillain-Barre syndrome.
J Neuroimmunol. 2018;323:109-114.
PubMed Abstract available

MOHAMMADZADEH A, Rad IA, Ahmadi-Salmasi B
CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients.
J Neuroimmunol. 2018;323:105-108.
PubMed Abstract available

KOSTIC M, Zivkovic N, Cvetanovic A, Stojanovic I, et al
Granulocyte-macrophage colony-stimulating factor as a mediator of autoimmunity in multiple sclerosis.
J Neuroimmunol. 2018;323:1-9.
PubMed Abstract available

AQEL SI, Granitto MC, Nuro-Gyina PK, Pei W, et al
Distinct roles for Blimp-1 in autoreactive CD4 T cells during priming and effector phase of autoimmune encephalomyelitis.
J Neuroimmunol. 2018;325:20-28.
PubMed Abstract available

ALROUJI M, Manouchehrinia A, Gran B, Constantinescu CS, et al
Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis.
J Neuroimmunol. 2018 Oct 9. pii: S0165-5728(18)30130.
PubMed Abstract available

SABRE L, Guptill JT, Russo M, Juel VC, et al
Circulating microRNA plasma profile in MuSK+ myasthenia gravis.
J Neuroimmunol. 2018 Oct 6. pii: S0165-5728(18)30383.
PubMed Abstract available

TAVAKOLPOUR V, Shokri G, Naser Moghadasi A, Mozafari Nahavandi P, et al
Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
J Neuroimmunol. 2018 Oct 4. pii: S0165-5728(18)30173.
PubMed Abstract available

SUGIMOTO K, Hiwasa T, Shibuya K, Hirano S, et al
Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis.
J Neuroimmunol. 2018;325:54-60.
PubMed Abstract available

September 2018

IWASA K, Yoshikawa H, Furukawa Y, Yamada M, et al
Programmed cell death ligand 1 expression is upregulated in the skeletal muscle of patients with myasthenia gravis.
J Neuroimmunol. 2018 Sep 27. pii: S0165-5728(18)30353.
PubMed Abstract available

CASTOLDI V, Marenna S, Santangelo R, d'Isa R, et al
Optic nerve involvement in experimental autoimmune encephalomyelitis to homologous spinal cord homogenate immunization in the dark agouti rat.
J Neuroimmunol. 2018;325:1-9.
PubMed Abstract available

JAFARZADEH A, Nemati M
Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties.
J Neuroimmunol. 2018;324:54-75.
PubMed Abstract available

MCWILLIAM O, Sellebjerg F, Marquart HV, von Essen MR, et al
B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTalpha and TGFbeta1 response.
J Neuroimmunol. 2018 Sep 7. pii: S0165-5728(18)30276.
PubMed Abstract available

August 2018

SALAPA HE, Johnson C, Hutchinson C, Popescu BF, et al
Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
J Neuroimmunol. 2018 Aug 29. pii: S0165-5728(18)30377.
PubMed Abstract available

FENOGLIO C, Oldoni E, Serpente M, De Riz MA, et al
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients.
J Neuroimmunol. 2018 Aug 27. pii: S0165-5728(18)30259.
PubMed Abstract available

HOU H, Cao R, Quan M, Sun Y, et al
Rapamycin and fingolimod modulate Treg/Th17 cells in experimental autoimmune encephalomyelitis by regulating the Akt-mTOR and MAPK/ERK pathways.
J Neuroimmunol. 2018;324:26-34.
PubMed Abstract available

MORIGUCHI K, Miyamoto K, Fukumoto Y, Kusunoki S, et al
4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice.
J Neuroimmunol. 2018;323:131-135.
PubMed Abstract available

CHEDRAWE MAJ, Holman SP, Lamport AC, Akay T, et al
Pioglitazone is superior to quetiapine, clozapine and tamoxifen at alleviating experimental autoimmune encephalomyelitis in mice.
J Neuroimmunol. 2018;321:72-82.
PubMed Abstract available

FEKI S, Gargouri S, Mejdoub S, Dammak M, et al
The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.
J Neuroimmunol. 2018;321:66-71.
PubMed Abstract available

FAGONE P, Mazzon E, Chikovani T, Saraceno A, et al
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis.
J Neuroimmunol. 2018;321:41-48.
PubMed Abstract available

LAI W, Kinoshita M, Peng A, Li W, et al
Does pregnancy affect women with multiple sclerosis? A prospective study in Western China.
J Neuroimmunol. 2018;321:24-28.
PubMed Abstract available

MOHAJER B, Abbasi N, Pishgar F, Abdolalizadeh A, et al
HLA-DRB1 polymorphism and susceptibility to multiple sclerosis in the Middle East North Africa region: A systematic review and meta-analysis.
J Neuroimmunol. 2018;321:117-124.
PubMed Abstract available

July 2018

MIYAKE S, Yamamura T
Gut environmental factors and multiple sclerosis.
J Neuroimmunol. 2018 Jul 27. pii: S0165-5728(17)30414.
PubMed Abstract available

NAKAMURA R, Makino T, Hanada T, Terakawa M, et al
Heterogeneity of auto-antibodies against nAChR in myasthenic serum and their pathogenic roles in experimental autoimmune myasthenia gravis.
J Neuroimmunol. 2018;320:64-75.
PubMed Abstract available

KARAMPOOR S, Zahednasab H, Etemadifar M, Keyvani H, et al
The levels of soluble forms of CD21 and CD83 in multiple sclerosis.
J Neuroimmunol. 2018;320:11-14.
PubMed Abstract available

June 2018

HAASE S, Wilck N, Kleinewietfeld M, Muller DN, et al
Sodium chloride triggers Th17 mediated autoimmunity.
J Neuroimmunol. 2018 Jun 30. pii: S0165-5728(17)30512.
PubMed Abstract available

SABERI R, Sharif M, Sarvi S, Aghayan SA, et al
Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis.
J Neuroimmunol. 2018 Jun 22. pii: S0165-5728(17)30579.
PubMed Abstract available

SERAFINI B, Zandee S, Rosicarelli B, Scorsi E, et al
Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption.
J Neuroimmunol. 2018;319:9-12.
PubMed

SERIZAWA K, Tomizawa-Shinohara H, Magi M, Yogo K, et al
Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;319:71-79.
PubMed Abstract available

TIJERO B, Del Pino R, Perez-Concha T, Acera MA, et al
Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy.
J Neuroimmunol. 2018;319:68-70.
PubMed Abstract available

YOSHIKURA N, Kimura A, Fukata M, Fukata Y, et al
Long-term clinical follow-up of a patient with non-paraneoplastic cerebellar ataxia associated with anti-mGluR1 autoantibodies.
J Neuroimmunol. 2018;319:63-67.
PubMed Abstract available

HIRATSUKA D, Furube E, Taguchi K, Tanaka M, et al
Remyelination in the medulla oblongata of adult mouse brain during experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;319:41-54.
PubMed Abstract available

AKAISHI T, Takahashi T, Nakashima I
Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis.
J Neuroimmunol. 2018;319:37-40.
PubMed Abstract available

FAGONE P, Mazzon E, Cavalli E, Bramanti A, et al
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
J Neuroimmunol. 2018 Jun 15. pii: S0165-5728(18)30141.
PubMed Abstract available

May 2018

DUPREE JL, Feinstein DL
Influence of diet on axonal damage in the EAE mouse model of multiple sclerosis.
J Neuroimmunol. 2018 May 20. pii: S0165-5728(18)30104.
PubMed Abstract available

BREUER J, Loser K, Mykicki N, Wiendl H, et al
Does the environment influence multiple sclerosis pathogenesis via UVB light and/or induction of vitamin D?
J Neuroimmunol. 2018 May 18. pii: S0165-5728(17)30478.
PubMed Abstract available

CHU F, Shi M, Zheng C, Shen D, et al
The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018;318:1-7.
PubMed Abstract available

SABRE L, Maddison P, Sadalage G, Ambrose PA, et al
Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.
J Neuroimmunol. 2018 May 8. pii: S0165-5728(18)30122.
PubMed Abstract available

April 2018

DUBEY D, Hinson SR, Jolliffe EA, Zekeridou A, et al
Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1year.
J Neuroimmunol. 2018 Apr 27. pii: S0165-5728(18)30160.
PubMed Abstract available

CASTANEDA-MORENO VA, De la Cruz-Mosso U, Torres-Carrillo N, Macias-Islas MA, et al
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
J Neuroimmunol. 2018 Apr 10. pii: S0165-5728(17)30593.
PubMed Abstract available

YAN J, Winterford CM, Catts VS, Pat BK, et al
Increased constitutive activation of NF-kappaB p65 (RelA) in peripheral blood cells of patients with progressive multiple sclerosis.
J Neuroimmunol. 2018 Apr 6. pii: S0165-5728(17)30536.
PubMed Abstract available

LI J, Qiu D, Chen Z, Du W, et al
miR-548k regulates CXCL13 expression in myasthenia gravis patients with thymic hyperplasia and in Jurkat cells.
J Neuroimmunol. 2018 Apr 4. pii: S0165-5728(18)30166.
PubMed Abstract available

March 2018

ZAGORITI Z, Lagoumintzis G, Perroni G, Papathanasiou G, et al
Evidence for association of STAT4 and IL12RB2 variants with Myasthenia gravis susceptibility: What is the effect on gene expression in thymus?
J Neuroimmunol. 2018 Mar 17. pii: S0165-5728(17)30559.
PubMed Abstract available

ALLENDER E, Deol H, Schram S, Maheras KJ, et al
Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE).
J Neuroimmunol. 2018 Mar 10. pii: S0165-5728(17)30466.
PubMed Abstract available

PAUNOVIC V, Petrovic IV, Milenkovic M, Janjetovic K, et al
Autophagy-independent increase of ATG5 expression in T cells of multiple sclerosis patients.
J Neuroimmunol. 2018 Mar 5. pii: S0165-5728(17)30538.
PubMed Abstract available

SMITH PA, Schmid C, Zurbruegg S, Jivkov M, et al
Fingolimod inhibits brain atrophy and promotes brain-derived neurotrophic factor in an animal model of multiple sclerosis.
J Neuroimmunol. 2018 Mar 3. pii: S0165-5728(17)30519.
PubMed Abstract available

ASHTARI F, Esmaeil N, Mansourian M, Poursafa P, et al
An 8-year study of people with multiple sclerosis in Isfahan, Iran: Association between environmental air pollutants and severity of disease.
J Neuroimmunol. 2018 Mar 2. pii: S0165-5728(18)30019.
PubMed Abstract available

February 2018

MONTEIRO A, Cruto C, Rosado P, Martinho A, et al
Characterization of circulating gamma-delta T cells in relapsing vs remission multiple sclerosis.
J Neuroimmunol. 2018 Feb 24. pii: S0165-5728(17)30533.
PubMed Abstract available

BARBOUR M, Wood R, Hridi SU, Wilson C, et al
The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.
J Neuroimmunol. 2018 Feb 24. pii: S0165-5728(17)30457.
PubMed Abstract available

ROZMILOWSKA IM, Adamczyk-Sowa MH
What is the role of interleukin 33 and ST2 receptor in myasthenia gravis?
J Neuroimmunol. 2018;315:50-57.
PubMed

KUHN I, Rogosch T, Schindler TI, Tackenberg B, et al
Serum titers of autoantibodies against alpha-synuclein and tau in child- and adulthood.
J Neuroimmunol. 2018;315:33-39.
PubMed Abstract available

GEORGE JD, Kim E, Spain R, Bourdette D, et al
Effects of lipoic acid on migration of human B cells and monocyte-enriched peripheral blood mononuclear cells in relapsing remitting multiple sclerosis.
J Neuroimmunol. 2018;315:24-27.
PubMed Abstract available

IP PP, Chung CY, Chang CC, Lee YF, et al
Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
J Neuroimmunol. 2018 Feb 8. pii: S0165-5728(17)30498.
PubMed Abstract available

January 2018

LIU C, Liu H, Jin H, Yue X, et al
Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis.
J Neuroimmunol. 2018 Jan 31. pii: S0165-5728(17)30560.
PubMed Abstract available

HOR JY, Lim TT, Cheng MC, Chia YK, et al
Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy.
J Neuroimmunol. 2018 Jan 30. pii: S0165-5728(17)30491.
PubMed Abstract available

RAHMAN MI, Jahan I, Khalid MM, Jahan I, et al
CD1A and CD1E gene polymorphisms are not associated with susceptibility to Guillain-Barre syndrome in the Bangladeshi population.
J Neuroimmunol. 2018;314:8-12.
PubMed Abstract available

MEYER SAUTEUR PM, Huizinga R, Tio-Gillen AP, Drenthen J, et al
Intrathecal antibody responses to GalC in Guillain-Barre syndrome triggered by Mycoplasma pneumoniae.
J Neuroimmunol. 2018;314:13-16.
PubMed Abstract available

LOSHAJ-SHALA A, Colzani M, Brezovska K, Poceva Panovska A, et al
Immunoproteomic identification of antigenic candidate Campylobacter jejuni and human peripheral nerve proteins involved in Guillain-Barre syndrome.
J Neuroimmunol. 2018 Jan 9. pii: S0165-5728(17)30422.
PubMed Abstract available

VOGRIG A, Pauletto G, Belgrado E, Pegolo E, et al
Effect of thymectomy on refractory autoimmune status epilepticus.
J Neuroimmunol. 2018 Jan 9. pii: S0165-5728(17)30485.
PubMed Abstract available

LV J, Li L, Li W, Ji K, et al
Role of the chemokine receptors CXCR3, CXCR4 and CCR7 in the intramuscular recruitment of plasmacytoid dendritic cells in dermatomyositis.
J Neuroimmunol. 2018 Jan 9. pii: S0165-5728(18)30015.
PubMed Abstract available

BAULINA N, Kulakova O, Kiselev I, Osmak G, et al
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission.
J Neuroimmunol. 2018 Jan 5. pii: S0165-5728(17)30447.
PubMed Abstract available

MASUDA H, Mori M, Umehara K, Furihata T, et al
Soluble CD40 ligand disrupts the blood-brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2018 Jan 3. pii: S0165-5728(17)30562.
PubMed Abstract available

OZKUL C, Guclu-Gunduz A, Irkec C, Fidan I, et al
Effect of combined exercise training on serum brain-derived neurotrophic factor, suppressors of cytokine signaling 1 and 3 in patients with multiple sclerosis.
J Neuroimmunol. 2018 Jan 3. pii: S0165-5728(17)30484.
PubMed Abstract available

December 2017

DETRICK B, Gangaputra S, Palsgrove DN, Heaney CD, et al
Elevated serum levels of IL-6 and CXCL9 in autoimmune retinopathy (AIR) patients.
J Neuroimmunol. 2017 Dec 29. pii: S0165-5728(17)30269.
PubMed Abstract available

IMITOLA J, Rasouli J, Watanabe F, Mahajan K, et al
Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions.
J Neuroimmunol. 2017 Dec 22. pii: S0165-5728(17)30304.
PubMed Abstract available

ROLLA S, De Mercanti SF, Bardina V, Horakova D, et al
Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses.
J Neuroimmunol. 2017;313:89-91.
PubMed Abstract available

BHAT R, Mahapatra S, Axtell RC, Steinman L, et al
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
J Neuroimmunol. 2017;313:77-81.
PubMed Abstract available

TAYLOR JM
Tissue resident macrophages are sufficient for demyelination during peripheral nerve myelin induced experimental autoimmune neuritis?
J Neuroimmunol. 2017;313:69-76.
PubMed Abstract available

LI R, Sun X, Shu Y, Wang Y, et al
Serum CCL20 and its association with SIRT1 activity in multiple sclerosis patients.
J Neuroimmunol. 2017;313:56-60.
PubMed Abstract available

GILLI F, Royce DB, DiSano KD, Pachner AR, et al
Pegylated interferon beta in the treatment of the Theiler's murine encephalomyelitis virus mouse model of multiple sclerosis.
J Neuroimmunol. 2017;313:34-40.
PubMed Abstract available

LIU J, Lian Z, Chen H, Shi Z, et al
Associations between tumor necrosis factor-alpha gene polymorphisms and the risk of Guillain-Barre syndrome and its subtypes: A systematic review and meta-analysis.
J Neuroimmunol. 2017;313:25-33.
PubMed Abstract available

AKAISHI T, Kaneko K, Himori N, Takeshita T, et al
Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica.
J Neuroimmunol. 2017;313:10-15.
PubMed Abstract available

GLENN JD, Xue P, Whartenby KA
Gemcitabine directly inhibits effector CD4 T cell activation and prevents experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2017 Dec 8. pii: S0165-5728(17)30303.
PubMed Abstract available

BANSI J, Koliamitra C, Bloch W, Joisten N, et al
Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
J Neuroimmunol. 2017 Dec 6. pii: S0165-5728(17)30420.
PubMed Abstract available

November 2017

KIM MJ, Lim JY, Park SA, Park SI, et al
Effective combination of methylprednisolone and interferon beta-secreting mesenchymal stem cells in a model of multiple sclerosis.
J Neuroimmunol. 2017 Nov 29. pii: S0165-5728(17)30134.
PubMed Abstract available

MONTELEONE F, Nicoletti CG, Stampanoni Bassi M, Iezzi E, et al
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain.
J Neuroimmunol. 2017 Nov 20. pii: S0165-5728(17)30179.
PubMed Abstract available

YOSHIKURA N, Kimura A, Hayashi Y, Inuzuka T, et al
Corrigendum to Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders" [J. Neuroimmunol. 310. (2017) 150-157].
J Neuroimmunol. 2017;312:66.
PubMed

WANG Y, Zhang W, Yin J, Lu Q, et al
Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
J Neuroimmunol. 2017;312:59-65.
PubMed Abstract available

HESSELMARK E, Bejerot S
Biomarkers for diagnosis of Pediatric Acute Neuropsychiatric Syndrome (PANS) - Sensitivity and specificity of the Cunningham Panel.
J Neuroimmunol. 2017;312:31-37.
PubMed Abstract available

SVEINSSON O, Granqvist M, Forslin Y, Blennow K, et al
Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis.
J Neuroimmunol. 2017;312:15-18.
PubMed Abstract available

ROLF L, Muris AH, Theunissen R, Hupperts R, et al
Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: Attenuation of progressive disturbances?
J Neuroimmunol. 2017 Nov 10. pii: S0165-5728(17)30208.
PubMed Abstract available

MAZDEH M, Moradi N, Khoshroo E, Shayesteh Z, et al
Down-regulation of TYK2, CBLB and LMP7 genes expression in relapsing-remitting multiple sclerosis patients treated with interferon-beta.
J Neuroimmunol. 2017 Nov 8. pii: S0165-5728(17)30405.
PubMed Abstract available

October 2017

LIU W, Zhu M, Yu Z, Yin D, et al
Therapeutic effects of diosgenin in experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2017 Oct 31. pii: S0165-5728(17)30191.
PubMed Abstract available

PALTERER B, Brugnolo F, Sieni E, Barilaro A, et al
Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation.
J Neuroimmunol. 2017;311:10-13.
PubMed Abstract available

LEI HW, Wang JY, Dang QJ, Yang F, et al
Neuropsychiatric involvement in lupus is associated with the Nogo-a/NgR1 pathway.
J Neuroimmunol. 2017;311:22-28.
PubMed Abstract available

HUANG ZL, Pandya D, Banta DK, Ansari MS, et al
Cyclophilin inhibitor NIM811 ameliorates experimental allergic encephalomyelitis.
J Neuroimmunol. 2017;311:40-48.
PubMed Abstract available

September 2017

FERNANDEZ HURST N, Zanetti SR, Baez NS, Bibolini MJ, et al
Diazepam treatment reduces inflammatory cells and mediators in the central nervous system of rats with experimental autoimmune encephalomyelitis.
J Neuroimmunol. 2017 Sep 30. pii: S0165-5728(17)30297.
PubMed Abstract available

MERKER M, Eichler S, Herrmann AM, Wiendl H, et al
Rivaroxaban ameliorates disease course in an animal model of multiple sclerosis.
J Neuroimmunol. 2017 Sep 21. pii: S1521-6616(17)30639.
PubMed Abstract available

BADIHIAN S, Manouchehri N, Badihian N
More evidence is needed to show any role of cytomegalovisrus and varicella zoster virus in pathogenesis of multiple sclerosis.
J Neuroimmunol. 2017 Sep 18. pii: S0165-5728(17)30401.
PubMed

VILLANI S, Zanotta N, Ambrogi F, Comar M, et al
Multiplex array analysis of circulating cytokines and chemokines in natalizumab-treated patients with multiple sclerosis.
J Neuroimmunol. 2017;310:91-96.
PubMed Abstract available

CHANGYALEKET B, Deliu Z, Chignalia AZ, Feinstein DL, et al
Heparanase: Potential roles in multiple sclerosis.
J Neuroimmunol. 2017;310:72-81.
PubMed Abstract available

JAHAN I, Ahammad RU, Farzana KS, Khalid MM, et al
Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barre syndrome in Bangladesh.
J Neuroimmunol. 2017;310:46-50.
PubMed Abstract available

NIELSEN BR, Ratzer R, Bornsen L, von Essen MR, et al
Characterization of naive, memory and effector T cells in progressive multiple sclerosis.
J Neuroimmunol. 2017;310:17-25.
PubMed Abstract available

HAITAO R, Huiqin L, Tao Q, Xunzhe Y, et al
Autoimmune encephalitis associated with vitiligo?
J Neuroimmunol. 2017;310:14-16.
PubMed Abstract available

DELGADO-GARCIA G, Corona-Vazquez T
IgG4-related disease and IgG4-mediated neurological autoimmune disorders: One and the same?
J Neuroimmunol. 2017;310:129-130.
PubMed

PENN M, Mausner-Fainberg K, Golan M, Karni A, et al
High serum levels of BMP-2 correlate with BMP-4 and BMP-5 levels and induce reduced neuronal phenotype in patients with relapsing-remitting multiple sclerosis.
J Neuroimmunol. 2017;310:120-128.
PubMed Abstract available

BENEDEK G, Zhang J, Nguyen H, Kent G, et al
Estrogen protection against EAE modulates the microbiota and mucosal-associated regulatory cells.
J Neuroimmunol. 2017;310:51-59.
PubMed Abstract available

ZHU DS, Yu L, Li M, Han L, et al
High serum creatinine is associated with reduction of vision impaired in patients with NMOSD.
J Neuroimmunol. 2017;310:32-37.
PubMed Abstract available

WANG J, Yang C, Zhao Q, Zhu Z, et al
Microglia activation induced by serum of SLE patients.
J Neuroimmunol. 2017;310:135-142.
PubMed Abstract available

LINDSEY JW
Antibodies to the Epstein-Barr virus proteins BFRF3 and BRRF2 cross-react with human proteins.
J Neuroimmunol. 2017;310:131-134.
PubMed Abstract available

ALVARENGA MP, Fernandez O, Leyva L, Campanella L, et al
The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro.
J Neuroimmunol. 2017;310:1-7.
PubMed Abstract available

VERCELLINO M, Trebini C, Capello E, Mancardi GL, et al
Inflammatory responses in Multiple Sclerosis normal-appearing white matter and in non-immune mediated neurological conditions with wallerian axonal degeneration: A comparative study.
J Neuroimmunol. 2017 Sep 8. pii: S0165-5728(17)30131.
PubMed Abstract available

LAZARIDIS K, Dalianoudis I, Baltatzidi V, Tzartos SJ, et al
Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis.
J Neuroimmunol. 2017 Sep 6. pii: S0165-5728(17)30332.
PubMed Abstract available

August 2017

YESHOKUMAR AK, Gordon-Lipkin E, Arenivas A, Cohen J, et al
Neurobehavioral outcomes in autoimmune encephalitis.
J Neuroimmunol. 2017 Aug 31. pii: S0165-5728(17)30274.
PubMed Abstract available

ALVAREZ BRAVO G, Yusta Izquierdo A, Carvalho Monteiro G, Sanchez I, et al
Cerebellopathy secondary to anti-peroxidase antibody-mediated toxicity. A special case of Hashimoto encephalopathy.
J Neuroimmunol. 2017 Aug 19. pii: S0165-5728(17)30265.
PubMed Abstract available

LIU RT, Zhang P, Yang CL, Pang Y, et al
ONX-0914, a selective inhibitor of immunoproteasome, ameliorates experimental autoimmune myasthenia gravis by modulating humoral response.
J Neuroimmunol. 2017 Aug 18. pii: S0165-5728(17)30182.
PubMed Abstract available

LISAK RP, Nedelkoska L, Benjamins JA, Schalk D, et al
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro.
J Neuroimmunol. 2017;309:88-99.
PubMed Abstract available

WALLWITZ U, Brock S, Schunck A, Wildemann B, et al
From dizziness to severe ataxia and dysarthria: New cases of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia suggest a broad clinical spectrum.
J Neuroimmunol. 2017;309:77-81.
PubMed Abstract available

PITAROKOILI K, Kohle F, Motte J, Fatoba O, et al
Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.
J Neuroimmunol. 2017;309:58-67.
PubMed Abstract available

DEMARSHALL C, Goldwaser EL, Sarkar A, Godsey GA, et al
Autoantibodies as diagnostic biomarkers for the detection and subtyping of multiple sclerosis.
J Neuroimmunol. 2017;309:51-57.
PubMed Abstract available

CAROTENUTO A, Scalia G, Ausiello F, Moccia M, et al
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients.
J Neuroimmunol. 2017;309:47-50.
PubMed Abstract available

MATHEY EK, Garg N, Park SB, Nguyen T, et al
Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
J Neuroimmunol. 2017;309:41-46.
PubMed Abstract available

KARAMPOOR S, Zahednasab H, Ramagopalan S, Mehrpour M, et al
Cytomegalovirus and varicella zoster virus seropositivity of Iranian patients with multiple sclerosis: A population-based study.
J Neuroimmunol. 2017;309:4-6.
PubMed Abstract available

BETTENCOURT A, Boleixa D, Guimaraes AL, Leal B, et al
The vitamin D receptor gene FokI polymorphism and Multiple Sclerosis in a Northern Portuguese population.
J Neuroimmunol. 2017;309:34-37.
PubMed Abstract available

PIERI M, Storto M, Pignalosa S, Zenobi R, et al
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation.
J Neuroimmunol. 2017;309:31-33.
PubMed Abstract available

LI X, Lin J, Pan S, Weng Y, et al
Suspected bacterial meningomyelitis: The first presenting clinical feature of neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2017;309:68-71.
PubMed Abstract available

KON T, Ueno T, Suzuki C, Nunomura J, et al
Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer.
J Neuroimmunol. 2017;309:38-40.
PubMed Abstract available

LIU J, Shi Z, Lian Z, Chen H, et al
Association of CD58 gene polymorphisms with NMO spectrum disorders in a Han Chinese population.
J Neuroimmunol. 2017;309:23-30.
PubMed Abstract available

HENDRICKX DAE, van Eden CG, Schuurman KG, Hamann J, et al
Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
J Neuroimmunol. 2017;309:12-22.
PubMed Abstract available

SUCHDEV K, Razmjou S, Venkatachalam P, Khan OA, et al
Late onset neuromyelitis optica mimicking an acute stroke in an elderly patient.
J Neuroimmunol. 2017;309:1-3.
PubMed Abstract available

AHMAD SF, Ansari MA, Nadeem A, Bakheet SA, et al
Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4+ T cells from a BTBR T+ Itpr3tf/J mouse model of autism.
J Neuroimmunol. 2017 Aug 9. pii: S0165-5728(17)30253.
PubMed Abstract available

WILDNER P, Selmaj KW
Multiple sclerosis: Skin-induced antigen-specific immune tolerance.
J Neuroimmunol. 2017 Aug 2. pii: S0165-5728(17)30263.
PubMed Abstract available

July 2017

YOSHIKURA N, Kimura A, Hayashi Y, Inuzuka T, et al
Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders.
J Neuroimmunol. 2017 Jul 19. pii: S0165-5728(17)30144.
PubMed Abstract available

June 2017

LIU G, Zhang F, Hu Y, Jiang Y, et al
Multiple sclerosis risk pathways differ in Caucasian and Chinese populations.
J Neuroimmunol. 2017;307:63-68.
PubMed Abstract available

ASMAIL A, Kesler A, Drory VE, Kolb H, et al
Effect of ethnic origin and gender on the clinical manifestations of myasthenia gravis among the Jewish population in Israel.
J Neuroimmunol. 2017;307:47-52.
PubMed Abstract available

FERNANDO KTM, James M
Early predictors of rapidly evolving multiple sclerosis: A case report.
J Neuroimmunol. 2017;307:42-46.
PubMed Abstract available

ZAHOOR I, Haq E
Multiple sclerosis in India: Iceberg or volcano.
J Neuroimmunol. 2017;307:27-30.
PubMed Abstract available

SAUER EL, Trifilieff E, Greer JM
Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
J Neuroimmunol. 2017;307:18-26.
PubMed Abstract available

SERAFINI B, Scorsi E, Rosicarelli B, Rigau V, et al
Massive intracerebral Epstein-Barr virus reactivation in lethal multiple sclerosis relapse after natalizumab withdrawal.
J Neuroimmunol. 2017;307:14-17.
PubMed Abstract available

KINOSHITA M, Daifu M, Tanaka K, Tanaka M, et al
Prognostic value of oligoclonal IgG bands in Japanese clinically isolated syndrome converting to clinically definite multiple sclerosis.
J Neuroimmunol. 2017;307:1-6.
PubMed Abstract available

BARROS PO, Dias ASO, Kasahara TM, Ornelas AMM, et al
Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients.
J Neuroimmunol. 2017;307:82-90.
PubMed Abstract available

May 2017

JING S, Song Y, Song J, Pang S, et al
Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis.
J Neuroimmunol. 2017 May 30. pii: S0165-5728(17)30074.
PubMed Abstract available

AKAISHI T, Nakashima I, Mugikura S, Aoki M, et al
Whole brain and grey matter volume of Japanese patients with multiple sclerosis.
J Neuroimmunol. 2017;306:68-75.
PubMed Abstract available

SISAY S, Lopez-Lozano L, Mickunas M, Quiroga-Fernandez A, et al
Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
J Neuroimmunol. 2017;306:40-45.
PubMed Abstract available

CONSTANTINESCU R, Krysl D, Andren K, Asztely F, et al
Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.
J Neuroimmunol. 2017;306:25-30.
PubMed Abstract available

BERMUDEZ-MORALES VH, Fierros G, Lopez RL, Martinez-Nava G, et al
Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults.
J Neuroimmunol. 2017;306:20-24.
PubMed Abstract available

RAMAKRISHNAN V, Akram Husain RS, Ahmed SS
Genetic predisposition of IL-10 promoter polymorphisms with risk of multiple sclerosis: A meta-analysis.
J Neuroimmunol. 2017;306:11-18.
PubMed Abstract available

SELMAJ I, Mycko MP, Raine CS, Selmaj KW, et al
The role of exosomes in CNS inflammation and their involvement in multiple sclerosis.
J Neuroimmunol. 2017;306:1-10.
PubMed Abstract available

April 2017

AGLIARDI C, Guerini FR, Zanzottera M, Bolognesi E, et al
Vitamin D-binding protein gene polymorphisms are not associated with MS risk in an Italian cohort.
J Neuroimmunol. 2017;305:92-95.
PubMed Abstract available

DENG B, Liu XN, Li X, Zhang X, et al
Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
J Neuroimmunol. 2017;305:84-91.
PubMed Abstract available

BENEDEK G, Zhang J, Nguyen H, Kent G, et al
Novel feedback loop between M2 macrophages/microglia and regulatory B cells in estrogen-protected EAE mice.
J Neuroimmunol. 2017;305:59-67.
PubMed Abstract available

ZHOU L, Huang Y, Li H, Fan J, et al
MOG-antibody associated demyelinating disease of the CNS: A clinical and pathological study in Chinese Han patients.
J Neuroimmunol. 2017;305:19-28.
PubMed Abstract available

SCOTT TF
Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model.
J Neuroimmunol. 2017;305:162-166.
PubMed Abstract available

PAWLAK-ADAMSKA E, Nowak O, Karabon L, Pokryszko-Dragan A, et al
PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS.
J Neuroimmunol. 2017;305:115-127.
PubMed Abstract available

KIMURA A, Takemura M, Saito K, Serrero G, et al
Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.
J Neuroimmunol. 2017;305:175-181.
PubMed Abstract available

February 2017

PANT AB, Wang Y, Mielcarz DW, Kasper EJ, et al
Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment.
J Neuroimmunol. 2017;303:22-30.
PubMed Abstract available

LAZARIDIS K, Baltatzidi V, Trakas N, Koutroumpi E, et al
Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains.
J Neuroimmunol. 2017;303:13-21.
PubMed Abstract available

WARNECKE A, Musunuri S, N'diaye M, Sandalova T, et al
Nitration of MOG diminishes its encephalitogenicity depending on MHC haplotype.
J Neuroimmunol. 2017;303:1-12.
PubMed Abstract available

January 2017

ZHANGBAO J, Zhou L, Li X, Cai T, et al
The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patients.
J Neuroimmunol. 2017;302:49-55.
PubMed Abstract available

December 2016

VOLPE G, Bernstock JD, Peruzzotti-Jametti L, Pluchino S, et al
Modulation of host immune responses following non-hematopoietic stem cell transplantation: Translational implications in progressive multiple sclerosis.
J Neuroimmunol. 2016 Dec 15. pii: S0165-5728(16)30312.
PubMed Abstract available

November 2016

COVACU R, Brundin L
Endogenous spinal cord stem cells in multiple sclerosis and its animal model.
J Neuroimmunol. 2016 Nov 15. pii: S0165-5728(16)30403.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: